drugset / Trial / NCT02161432

Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers

NCT02161432

Phase 1 Completed 17 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

To determine the relative bioavailability of an BI 187004 tablet formulation compared to an oral solution of BI 187004 and to assess the influence of food on the bioavailability of the tablet formulation.

Timeline

Start
2014-06
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 187004 Small molecule Oral

Indications

No indication recorded.